News25/Ratings11
News · 26 weeks38-48%
2025-10-262026-04-19
Mix3890d
- Insider19(50%)
- Analyst11(29%)
- SEC Filings5(13%)
- Other2(5%)
- Offering1(3%)
Latest news
25 items- SECSEC Form 10-Q filed by MiniMed Group Inc.10-Q - MiniMed Group, Inc. (0002062583) (Filer)
- PRMiniMed to announce financial results for its fourth quarter and full fiscal year 2026NORTHRIDGE, Calif., April 13, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2026 on Wednesday, June 3, 2026. A news release will be issued at approximately 3:45 a.m. Pacific Daylight Time (PDT) and will be available at https://news.minimed.com. The news release will include summary financial information for the company's fourth quarter and full fiscal year 2026, which will end on Friday, April 24, 2026. MiniMed will host a webcast at 5:45 a.m. P
- ANALYSTBTIG Research initiated coverage on MiniMed with a new price targetBTIG Research initiated coverage of MiniMed with a rating of Buy and set a new price target of $25.00
- ANALYSTDeutsche Bank initiated coverage on MiniMed with a new price targetDeutsche Bank initiated coverage of MiniMed with a rating of Buy and set a new price target of $20.00
- ANALYSTBofA Securities initiated coverage on MiniMed with a new price targetBofA Securities initiated coverage of MiniMed with a rating of Buy and set a new price target of $27.00
- ANALYSTPiper Sandler initiated coverage on MiniMed with a new price targetPiper Sandler initiated coverage of MiniMed with a rating of Neutral and set a new price target of $16.00
- ANALYSTMizuho initiated coverage on MiniMed with a new price targetMizuho initiated coverage of MiniMed with a rating of Outperform and set a new price target of $21.00
- ANALYSTMorgan Stanley initiated coverage on MiniMed with a new price targetMorgan Stanley initiated coverage of MiniMed with a rating of Overweight and set a new price target of $19.00
- ANALYSTCitigroup initiated coverage on MiniMed with a new price targetCitigroup initiated coverage of MiniMed with a rating of Buy and set a new price target of $23.00
- ANALYSTEvercore ISI initiated coverage on MiniMed with a new price targetEvercore ISI initiated coverage of MiniMed with a rating of Outperform and set a new price target of $20.00
- ANALYSTWells Fargo initiated coverage on MiniMed with a new price targetWells Fargo initiated coverage of MiniMed with a rating of Overweight and set a new price target of $26.00
- ANALYSTWilliam Blair initiated coverage on MiniMedWilliam Blair initiated coverage of MiniMed with a rating of Outperform
- ANALYSTGoldman initiated coverage on MiniMed with a new price targetGoldman initiated coverage of MiniMed with a rating of Buy and set a new price target of $24.00
- INSIDERSEC Form 4 filed by Dallara Que4 - MiniMed Group, Inc. (0002062583) (Issuer)
- SECMiniMed Group Inc. filed SEC Form 8-K: Leadership Update8-K - MiniMed Group, Inc. (0002062583) (Filer)
- SECMiniMed Group Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - MiniMed Group, Inc. (0002062583) (Filer)
- PRMiniMed Announces FDA Clearance of MiniMed Flex™, the Company's Smallest Insulin Pump Featuring Its First Smartphone-Controlled DesignMiniMed Flex™ is about half the size of the previous generation MiniMed™ 780G system, and features the SmartGuard™ adaptive algorithm to automatically adjust and autocorrect insulin delivery in real-timeNORTHRIDGE, Calif., March 18, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced U.S. Food and Drug Administration (FDA) clearance of MiniMed Flex™, a next-generation discreet, smartphone-controlled insulin pump designed to fit seamlessly into everyday life. MiniMed Flex™ represents a major redesign of MiniMed's insulin pumps.About
- INSIDEROfficer Gyurci John was granted 15,322 shares (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDEROfficer Chandrasena Gillian was granted 129,765 shares (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDEROfficer Wills Courtney Nelson was granted 55,063 shares (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDEROfficer Dianaty Ali was granted 191,258 shares (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDEREVP, Chief Financial Officer Spooner Chad was granted 269,401 shares (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERChief Executive Officer Dallara Que was granted 621,563 shares (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 4 filed by MiniMed Group Inc.4 - MiniMed Group, Inc. (0002062583) (Issuer)